logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
S

Sirpa Leppä

University of Helsinki

50H指数
516论文数
1.2W被引数
收录论文 80
发表时间
logo
Folate receptor beta targeting of tumor-associated macrophages improves lymphoma cell responses to CD19 CAR T cells靶向肿瘤相关巨噬细胞的叶酸受体β可改善淋巴瘤细胞对CD19 CAR T细胞的反应
errHemaSphere
IF14.6
err2026-05-29
err0
errOAAI
errKerttu Kalander; Katri Oksa; Selma Sorri; Hector Monzo; Suvi-Katri Leivonen; Päivi M. Ojala; Sirpa Leppä
err分享
err收藏
A targeted circulating tumor DNA landscape of copy number aberrations in large B-cell lymphomas大B细胞淋巴瘤中靶向循环肿瘤DNA拷贝数异常景观
errLeukemia
IF13.4
err2026-04-22
err0
errOAAI
errMaare Arffman; Leo Meriranta; Judit Jørgensen; Marja-Liisa Karjalainen-Lindsberg; Klaus Beiske; Mette Pedersen; Kristina Drott; Øystein Fluge; Sirkku Jyrkkiö; Peter Brown; Harald Holte; Sirpa Leppä
err分享
err收藏
Plasma proteomics to explore benefit from anti-PD-(L)1 in advanced solid tumors: a prospective pilot study血浆蛋白质组学探索抗PD-(L)1在晚期实体瘤中的益处: 一项前瞻性先导研究
errScientific Reports
IF3.9
err2025-12-06
err0
errOAAI
errAntti Tikkanen; Sanna Iivanainen; Peeter Karihtala; Sirpa Leppä; Jussi Koivunen
err分享
err收藏
Transformation and causes of death in follicular lymphoma: A Finnish nationwide population-based study滤泡性淋巴瘤的转归与死亡原因：一项芬兰全国性基于人群的研究
errBritish Journal of Haematology
IF3.8
err2025-09-25
err0
errOAAI
errIlja Kalashnikov; Taina Reunamo; Tomas Tanskanen; Leevi Viisanen; Nea Malila; Sirkku Jyrkkiö; Sirpa Leppä
err分享
err收藏
Large B-cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up弥漫大B细胞淋巴瘤（LBCL）：EHA 诊断、治疗和随访临床实践指南
errHemaSphere
IF14.6
err2025-09-23
err0
errOAAI
errCatherine Thieblemont; Maria Gomes Da Silva; Sirpa Leppä; Georg Lenz; Anne-Ségolène Cottereau; Christopher Fox; Armando Lopez-Guillermo; Timothy Illidge; Wojciech Jurczak; Hans Eich; Igor Aurer; Marek Trneny; Andy Andreas Rosenwald; Andrew Davies; Ben (Gerben) Zwezerijnen; Natacha Bolanos; Maja Marković; Jean-Philippe Jais; Florence Broussais; Martin Dreyling; Umberto Vitolo; Hervé Tilly; Marie-José Kersten
err分享
err收藏
Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe弥合欧洲大B细胞淋巴瘤疗法在临床试验可及性和报销方面的差距
errHemaSphere
IF14.6
err2025-09-23
err0
errOAAI
errFlorence Broussais; Elise Pennings; Natacha Bolanos; Lorna Warwick; Robin Doeswijk; Gauthier Quinonez; Andrii Lebeda; Maria Gomes Da Silva; Sirpa Leppä; Georg Lenz; Anne-Ségolène Cottereau; Christopher Fox; Armando Lopez-Guillermo; Timothy Illidge; Wojciech Jurczak; Hans Eich; Igor Aurer; Marek Trneny; Andy Andreas Rosenwald; Andrew Davies; Ben (Gerben) Zwezerijnen; Jean-Philippe Jais; Martin Dreyling; Umberto Vitolo; Hervé Tilly; Catherine Thieblemont; Marie Jose Kersten
err分享
err收藏
Fixed-Duration Epcoritamab Plus R2 Drives Favorable Outcomes in Relapsed or Refractory Follicular Lymphoma固定疗程的Epcoritamab联合R2方案可改善复发或难治性滤泡性淋巴瘤患者的预后。
errBlood
IF23.1
err2025-09-10
err0
errOAAI
errLorenzo Falchi; Anna Sureda; Sirpa Leppä; Joost S.P. Vermaat; Marcel Nijland; Jacob Haaber Christensen; Sven de Vos; Harald Holte; Reid W. Merryman; Pieternella J. Lugtenburg; Pau Abrisqueta; Kim M. Linton; Gauri Sunkersett; Daniela Hoehn; Ali Rana; Aqeel Abbas; Jennifer Marek; Yi Hao; Andrew J. Steele; Christopher Morehouse; Martin Hutchings; David Belada
err分享
err收藏
Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patientsBrentuximab vedotin、环磷酰胺、多柔比星和泼尼松用于老年晚期霍奇金淋巴瘤患者
errHemaSphere
IF14.6
err2025-08-18
err0
errOAAI
errPaul J. Bröckelmann; Boris Böll; Daniel Molin; Gundolf Schneider; Sirpa Leppä; Julia Meissner; Peter Kamper; Martin Hutchings; Jacob H. Christensen; Ulf Schnetzke; Michael Fuchs; Janina Jablonski; Dennis A. Eichenauer; Bastian von Tresckow; Wolfram Klapper; Carsten Kobe; Peter Borchmann; Alexander Fosså
err分享
err收藏
Circulating tumor DNA determinants of response and outcome in relapsed/refractory mantle cell lymphoma循环肿瘤DNA在复发/难治性套细胞淋巴瘤中的应答和结局预测因素
errBlood Advances
IF7.1
err2025-05-27
err0
errOAAI
errLeo Meriranta; Rasmus Rask Kragh Jørgensen; Annika Pasanen; Arne Kolstad; Martin Hutchings; Carsten Utoft Niemann; Tarec Christoffer El-Galaly; Jon Riise; Jacob Haaber Christensen; Kristina Sonnevi; Lone Bredo Pedersen; Karin Fahl Wader; Ingrid Glimelius; Sirpa Leppä; Mats Jerkeman
err分享
err收藏
Characterization of cancer-associated fibroblasts and their spatial architecture reveals heterogeneity and survival associations in classic Hodgkin lymphoma癌症相关成纤维细胞的表征及其空间结构揭示了经典霍奇金淋巴瘤的异质性和生存关联
errHEMASPHERE
IF14.6
err2025-05-27
err0
errOAAI
errLeivonen, Suvi-Katri; Karihtala, Kristiina; Pellinen, Teijo; Karjalainen-Lindsberg, Marja-Liisa; Aoki, Tomohiro; Steidl, Christian; Leppa, Sirpa
err分享
err收藏
Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG-NLG phase II BVB trialBrentuximab vedotin单药治疗是对于不适合进行治愈性化疗的老年经典型霍奇金淋巴瘤患者的可行且有效的治疗方案：来自前瞻性GHSG-NLG II期BVB试验的结果
errHEMASPHERE
IF14.6
err2025-03-21
err0
errOAAI
errFossa, Alexander; Molin, Daniel; Broeckelmann, Paul J.; Schneider, Gundolf; Schnetzke, Ulf; Linderoth, Johan; Kamper, Peter M. H.; Leppa, Sirpa M.; Meissner, Julia; Schaub, Valdete; Lia, Kjersti; Fuchs, Michael; Borchmann, Peter; Boell, Boris
err分享
err收藏
Impact of Rituximab Maintenance Added to Ibrutinib-Containing Regimens with and without ASCT in Younger, Previously Untreated MCL Patients: An Analysis of the Triangle Data Embedded in the Multiply Project利妥昔单抗维持治疗联合含伊布替尼方案（含或不含ASCT）对年轻、初治套细胞淋巴瘤患者的影响：一项来自Multiply项目嵌入Triangle数据集的分析
errBLOOD
IF23.1
err2024-11-05
err3
PREAI
errLadetto, Marco; Gutmair, Katja; Doorduijn, Jeanette K.; Gine, Eva; Jerkeman, Mats; Walewski, Jan; Hutchings, Martin; Mey, Ulrich; Riise, Jon; Trneny, Marek; Vergote, Vibeke K. J.; Stefani, Piero Maria; Horowitz, Netanel A.; da Silva, Maria Gomes; Leppa, Sirpa; Jiang, Linmiao; Pott, Christiane; Klapper, Wolfram; Schmidt, Christian; Unterhalt, Michael; Dreyling, Martin; Hoster, Eva
err分享
err收藏
Role of Autologous Stem Cell Transplantation in the Context of Ibrutinib-Containing First-Line Treatment in Younger Patients with Mantle Cell Lymphoma: Results from the Randomized Triangle Trial By the European MCL Network自体干细胞移植在含伊布替尼的一线治疗背景下年轻套细胞淋巴瘤患者中的作用：欧洲MCL网络随机Triangle试验结果
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errDreyling, Martin; Doorduijn, Jeanette K.; Gine, Eva; Jerkeman, Mats; Walewski, Jan; Hutchings, Martin; Mey, Ulrich; Riise, Jon; Trneny, Marek; Vergote, Vibeke K. J.; Donnarumma, Daniela; Shpilberg, Ofer; da Silva, Maria Gomes; Leppa, Sirpa; Jiang, Linmiao; Pott, Christiane; Klapper, Wolfram; Schmidt, Christian; Unterhalt, Michael; Ladetto, Marco; Hoster, Eva
err分享
err收藏
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre studyEpcoritamab单药治疗复发性或难治性滤泡性淋巴瘤患者 (EPCORE NHL-1): 单臂多中心研究的2期队列
errLANCET HAEMATOLOGY
IF17.7
err2024-08-01
err8
PREAI
errLinton, Kim M.; Vitolo, Umberto; Jurczak, Wojciech; Lugtenburg, Pieternella J.; Gyan, Emmanuel; Sureda, Anna; Christensen, Jacob Haaber; Hess, Brian; Tilly, Herve; Cordoba, Raul; Lewis, David John; Okada, Craig; Hutchings, Martin; Clausen, Michael Roost; Sancho, Juan-Manuel; Cochrane, Tara; Leppa, Sirpa; Chamuleau, Martine E. D.; Gernhardt, Diana; Altintas, Isil; Liu, Yan; Ahmadi, Tahamtan; Dinh, Minh H.; Hoehn, Daniela; Favaro, Elena; Elliott, Brian; Thieblemont, Catherine; Vose, Julie M.
err分享
err收藏
Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas
errMED
IF11.8
err2024-06-01
err0
errOAAI
errArffman, Maare; Meriranta, Leo; Autio, Matias; Holte, Harald; Jorgensen, Judit; Brown, Peter; Jyrkkio, Sirkku; Jerkeman, Mats; Drott, Kristina; Fluge, Oystein; Bjorkholm, Magnus; Karjalainen-Lindsberg, Marja-Liisa; Beiske, Klaus; Pedersen, Mette olgod; Leivonen, Suvi-Katri; Leppa, Sirpa
err分享
err收藏
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
errLANCET
IF88.5
err2024-05-01
err13
errOAAI
errDreyling, Martin; Doorduijn, Jeanette; Gine, Eva; Jerkeman, Mats; Walewski, Jan; Hutchings, Martin; Mey, Ulrich; Riise, Jon; Trneny, Marek; Vergote, Vibeke; Shpilberg, Ofer; da Silva, Maria Gomes; Leppa, Sirpa; Jiang, Linmiao; Stilgenbauer, Stephan; Kerkhoff, Andrea; Jachimowicz, Ron; Celli, Melania; Hess, Georg; Arcaini, Luca; Visco, Carlo; van Meerten, Tom; Wirths, Stefan; Zinzani, Pier Luigi; Novak, Urban; Herhaus, Peter; Benedetti, Fabio; Sonnevi, Kristina; Hanoun, Christine; Haenel, Matthias; Dierlamm, Judith; Pott, Christiane; Klapper, Wolfram; Goezel, Doendue; Schmidt, Christian; Unterhalt, Michael; Ladetto, Marco; Hoster, Eva
err分享
err收藏
Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell LymphomaB细胞淋巴瘤中KLHL6促进致癌抗原受体信号传导的破坏
errBLOOD CANCER DISCOVERY
IF11.5
err2024-04-17
err0
errOAAI
errMeriranta, Leo; Sorri, Selma; Huse, Kanutte; Liu, Xiaonan; Spasevska, Ivana; Zafar, Sadia; Chowdhury, Iftekhar; Dufva, Olli; Sahlberg, Eerika; Tandaric, Luka; Karjalainen-Lindsberg, Marja-Liisa; Hyytiainen, Marko; Varjosalo, Markku; Myklebust, June H.; Leppa, Sirpa
err分享
err收藏
Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival
errBREAST CANCER RESEARCH
IF5.6
err2024-04-09
err2
errOAAI
errKarihtala, Peeter; Leivonen, Suvi-Katri; Puistola, Ulla; Urpilainen, Elina; Jaaskelainen, Anniina; Leppa, Sirpa; Jukkola, Arja
err分享
err收藏
Safety and efficacy of HMPL-523 (Syk inhibitor) in patients with relapsed or refractory lymphoma
errCANCER RESEARCH
IF16.6
err2024-04-05
err0
PREAI
errStrati, Paolo; Gonzalez-Barca, Eva; Morillo, Daniel; Ahmed, Sairah; Chraniuk, Dominik; Leppa, Sirpa; Vicente, Fatima de la Cruz; Centkowski, Piotr; Pillai, Rathi N.; Nanda, Shivani; Khullar, Alisha; Hahka-Kemppinen, Marjo; Jayaprakash, Vijayvel; Gritti, Giuseppe
err分享
err收藏
A phase 1 study of JBH492, an anti C-C chemokine receptor 7 antibodydrug conjugate (anti-CCR7 ADC), assessing safety and efficacy in lymphoid malignancies
errCANCER RESEARCH
IF16.6
err2024-04-05
err2
PREAI
errAbrisqueta, Pau; Marks, Reinhard; Avivi, Irit; Wermke, Martin; Lim, Francesca; Kim, Tae Min; Touzon, Alba Cabirta; Karihtala, Kristiina; Makita, Shinichi; Werner, Lillian; Tanaka, Chiaki; Dang, Anhthu; Chaudhury, Anwesha; Rice, Seth; Chowdhury, Rowshan; Knee, Deborah; Gomezcarrillo, Belen; Furutani, Elissa; Izutsu, Koji; Leppa, Sirpa
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
E
Elı́as Campo
H 指数: 173 · 论文数: 1.6K
P
Philippe Moreau
H 指数: 159 · 论文数: 2.3K
R
Randy D. Gascoyne
H 指数: 152 · 论文数: 1.0K
M
Michael S. Lawrence
H 指数: 145 · 论文数: 648
G
Gilles Salles
H 指数: 129 · 论文数: 1.7K
查看更多